Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Iris Medits

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
NPJ Vaccines|September 12, 2019
Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccinationVictoria Bradt, Stefan Malafa, Amrei von Braun, et al.
NPJ Vaccines|August 4, 2023
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variantsDavid N Springer, Michael Bauer, Iris Medits, et al.
Plos Neglected Tropical Diseases|February 5, 2020
Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humansStefan Malafa, Iris Medits, Judith H Aberle, et al.
Nature|June 25, 2016
Structural basis of potent Zika-dengue virus antibody cross-neutralizationGiovanna Barba-Spaeth, Wanwisa Dejnirattisai, Alexander Rouvinski, et al.
Frontiers in Immunology|August 5, 2022
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 InfectionsIris Medits, David N Springer, Marianne Graninger, et al.
Nature|September 15, 2016
Erratum: Structural basis of potent Zika-dengue virus antibody cross-neutralizationGiovanna Barba-Spaeth, Wanwisa Dejnirattisai, Alexander Rouvinski, et al.
Frontiers in Medicine|December 2, 2020
Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease SeverityMaximilian Koblischke, Marianna T Traugott, Iris Medits, et al.
The Lancet. Microbe|June 8, 2026
Widespread circulation of Alongshan virus in Austria and serological evidence for infection in humans: a nationwide molecular and serological observational studyDavid M Florian, Paul Jetzinger, Anna-Margarita Schötta, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
NPJ Vaccines|September 12, 2019
Pre-existing yellow fever immunity impairs and modulates the antibody response to tick-borne encephalitis vaccinationVictoria Bradt, Stefan Malafa, Amrei von Braun, et al.
NPJ Vaccines|August 4, 2023
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variantsDavid N Springer, Michael Bauer, Iris Medits, et al.
Plos Neglected Tropical Diseases|February 5, 2020
Impact of flavivirus vaccine-induced immunity on primary Zika virus antibody response in humansStefan Malafa, Iris Medits, Judith H Aberle, et al.
Nature|June 25, 2016
Structural basis of potent Zika-dengue virus antibody cross-neutralizationGiovanna Barba-Spaeth, Wanwisa Dejnirattisai, Alexander Rouvinski, et al.
Frontiers in Immunology|August 5, 2022
Different Neutralization Profiles After Primary SARS-CoV-2 Omicron BA.1 and BA.2 InfectionsIris Medits, David N Springer, Marianne Graninger, et al.
Nature|September 15, 2016
Erratum: Structural basis of potent Zika-dengue virus antibody cross-neutralizationGiovanna Barba-Spaeth, Wanwisa Dejnirattisai, Alexander Rouvinski, et al.
Frontiers in Medicine|December 2, 2020
Dynamics of CD4 T Cell and Antibody Responses in COVID-19 Patients With Different Disease SeverityMaximilian Koblischke, Marianna T Traugott, Iris Medits, et al.
The Lancet. Microbe|June 8, 2026
Widespread circulation of Alongshan virus in Austria and serological evidence for infection in humans: a nationwide molecular and serological observational studyDavid M Florian, Paul Jetzinger, Anna-Margarita Schötta, et al.
Pageof 2